Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,095 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Landscape and perspectives of macrophage -targeted cancer therapy in clinical trials.
Wang S, Yang Y, Ma P, Huang H, Tang Q, Miao H, Fang Y, Jiang N, Li Y, Zhu Q, Tao W, Zha Y, Li N. Wang S, et al. Among authors: miao h. Mol Ther Oncolytics. 2022 Feb 22;24:799-813. doi: 10.1016/j.omto.2022.02.019. eCollection 2022 Mar 17. Mol Ther Oncolytics. 2022. PMID: 35317518 Free PMC article. Review.
The state of the art of bispecific antibodies for treating human malignancies.
Wang S, Chen K, Lei Q, Ma P, Yuan AQ, Zhao Y, Jiang Y, Fang H, Xing S, Fang Y, Jiang N, Miao H, Zhang M, Sun S, Yu Z, Tao W, Zhu Q, Nie Y, Li N. Wang S, et al. Among authors: miao h. EMBO Mol Med. 2021 Sep 7;13(9):e14291. doi: 10.15252/emmm.202114291. Epub 2021 Aug 24. EMBO Mol Med. 2021. PMID: 34431224 Free PMC article. Review.
KRAS Mutation in Rare Tumors: A Landscape Analysis of 3453 Chinese Patients.
Wang S, Li Q, Ma P, Fang Y, Yu Y, Jiang N, Miao H, Tang Q, Yang Y, Xing S, Chen R, Yi X, Li N. Wang S, et al. Among authors: miao h. Front Mol Biosci. 2022 Mar 11;9:831382. doi: 10.3389/fmolb.2022.831382. eCollection 2022. Front Mol Biosci. 2022. PMID: 35359599 Free PMC article.
Association between germ-line HLA and immune-related adverse events.
Jiang N, Yu Y, Zhang M, Tang Y, Wu D, Wang S, Fang Y, Zhang Y, Meng L, Li Y, Miao H, Ma P, Huang H, Li N. Jiang N, et al. Among authors: miao h. Front Immunol. 2022 Sep 13;13:952099. doi: 10.3389/fimmu.2022.952099. eCollection 2022. Front Immunol. 2022. PMID: 36177028 Free PMC article.
Drug conjugate-based anticancer therapy - Current status and perspectives.
Yang Y, Wang S, Ma P, Jiang Y, Cheng K, Yu Y, Jiang N, Miao H, Tang Q, Liu F, Zha Y, Li N. Yang Y, et al. Among authors: miao h. Cancer Lett. 2023 Jan 1;552:215969. doi: 10.1016/j.canlet.2022.215969. Epub 2022 Oct 22. Cancer Lett. 2023. PMID: 36279982 Free article. Review.
The reliability and integrity of overall survival data based on follow-up records only and potential solutions to the challenges.
Huang H, Tang Y, Yu Y, Yu A, Wu D, Fang H, Wang S, Sun C, Wang X, Fan Q, Fang Y, Tang Q, Jiang N, Du J, Miao H, Bai Y, Ma P, Xing S, Cui D, Miao S, Jiang Y, Zhu J, Zhu Q, Leng Y, Guo LW, Liao S, Shao Y, Song Y, Liu Z, Hong M, Luo S, Xu B, Lan G, Li N. Huang H, et al. Among authors: miao h, miao s. Lancet Reg Health West Pac. 2022 Nov 18;31:100624. doi: 10.1016/j.lanwpc.2022.100624. eCollection 2023 Feb. Lancet Reg Health West Pac. 2022. PMID: 36426285 Free PMC article. Review.
Targeting rare tumors: new focus for clinical research in China.
Wang S, Jiang Y, Miao H, Fang Y, Jiang N, Yu Y, Ma P, Tang Q, Cui D, Fang H, Huang H, Fan Q, Sun C, Yu A, Miao S, Du J, Zhu J, Wang Y, Li N. Wang S, et al. Among authors: miao h, miao s. EMBO Mol Med. 2023 Jan 11;15(1):e16415. doi: 10.15252/emmm.202216415. Epub 2022 Nov 28. EMBO Mol Med. 2023. PMID: 36437781 Free PMC article.
2,095 results